Oral Pantoprazole for Acid Suppression in the Treatment of Patients with Zollinger-Ellison Syndrome

Abstract

Pantoprazole was able to control acid hypersecretion in ZES patients when administered in doses between 40 and 160 mg daily. An initial dose of 120 mg given before further titration of the drug regimen appears to be a reasonable therapeutic strategy.